StockData
Passage BIO, Inc. logo

Passage BIO, Inc. (PASG) stock

PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.22+0.09 (+2.18%)

Close on Nov 17, 2026Market cap $13.58MP/E –Yield –

Passage BIO market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Passage BIO's market cap was $12.87M on Nov 11, 2026, against $28.07M a year earlier. Over the last 5 years it ranged from $11.10M to $351.80M, with a median of $44.37M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$12.87M-65.7%
2025Dec 31, 2025$37.51M+4.4%
2024Dec 31, 2024$35.93M-36.7%
2023Dec 29, 2023$56.78M-26.5%
2022Dec 30, 2022$77.20M-78.1%
2021Dec 31, 2021$351.80M-70.5%
2020Dec 31, 2020$1.19B–

More Passage BIO figures

See a number that looks wrong?